EP1223958A4 - Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions - Google Patents

Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

Info

Publication number
EP1223958A4
EP1223958A4 EP00992133A EP00992133A EP1223958A4 EP 1223958 A4 EP1223958 A4 EP 1223958A4 EP 00992133 A EP00992133 A EP 00992133A EP 00992133 A EP00992133 A EP 00992133A EP 1223958 A4 EP1223958 A4 EP 1223958A4
Authority
EP
European Patent Office
Prior art keywords
autoimmune
preparation
treatment
composition
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00992133A
Other languages
German (de)
French (fr)
Other versions
EP1223958A2 (en
Inventor
Daniel H Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cel Sci Corp
Original Assignee
Cel Sci Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cel Sci Corp filed Critical Cel Sci Corp
Priority to EP05014859A priority Critical patent/EP1598370A3/en
Priority to EP08156124A priority patent/EP1964854A2/en
Publication of EP1223958A2 publication Critical patent/EP1223958A2/en
Publication of EP1223958A4 publication Critical patent/EP1223958A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP00992133A 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions Withdrawn EP1223958A4 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05014859A EP1598370A3 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
EP08156124A EP1964854A2 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16173499P 1999-10-27 1999-10-27
US161734P 1999-10-27
PCT/US2000/041646 WO2001036448A2 (en) 1999-10-27 2000-10-27 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05014859A Division EP1598370A3 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

Publications (2)

Publication Number Publication Date
EP1223958A2 EP1223958A2 (en) 2002-07-24
EP1223958A4 true EP1223958A4 (en) 2004-07-21

Family

ID=22582487

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08156124A Ceased EP1964854A2 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
EP00992133A Withdrawn EP1223958A4 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP08156124A Ceased EP1964854A2 (en) 1999-10-27 2000-10-27 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

Country Status (4)

Country Link
EP (2) EP1964854A2 (en)
JP (1) JP2003514828A (en)
AU (1) AU4134901A (en)
WO (1) WO2001036448A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2328356A1 (en) 1999-12-22 2001-06-22 Itty Atcravi Recreational vehicles
US7645743B2 (en) * 1999-12-22 2010-01-12 Altermune, Llc Chemically programmable immunity
JP2003533542A (en) * 2000-05-24 2003-11-11 セル−サイ・コーポレーシヨン T cell binding ligands, peptide constructs containing them and their use for treating immune disorders
US20060134126A1 (en) * 2002-01-23 2006-06-22 Daniel Zimmerman Peptide constructs for treating disease
AU2003237493A1 (en) * 2002-01-23 2003-09-02 Cel-Sci Corporation Methods for treating diseases or conditions with peptide constructs
WO2004106365A2 (en) * 2003-05-28 2004-12-09 Aventis Pasteur, Inc. Modulatory peptide motifs for inducing th1 or th2 immune response
ES2539490T3 (en) * 2005-06-13 2015-07-01 Cleveland Biolabs, Inc. Methods to protect against apoptosis using lipopeptides
CA2629881C (en) 2005-11-17 2017-09-12 Rikard Holmdahl A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif
US20160158330A1 (en) * 2006-05-31 2016-06-09 Cel-Sci Corporation Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
WO2009114869A2 (en) * 2008-03-14 2009-09-17 Cel-Sci Corporation Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
US10179174B2 (en) 2011-05-25 2019-01-15 Cel-Sci Corp. Method for inducing an immune response and formulations thereof
WO2013123432A2 (en) 2012-02-16 2013-08-22 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
EP3612215A4 (en) 2017-04-20 2021-05-26 aTyr Pharma, Inc. Compositions and methods for treating lung inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030706A1 (en) * 1997-01-07 1998-07-16 The University Of Tennessee Research Corporation Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
WO1999016710A1 (en) * 1997-09-30 1999-04-08 Cel-Sci Corporation Immunogenic conjugated polypeptide for treatment of herpes simplex virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68924850T2 (en) * 1988-06-14 1996-10-10 Cell Med Inc HETERO FUNCTIONAL CELLULAR IMMUNOLOGICAL REAGENTS, VACCINATES THEREOF AND METHOD OF USE.
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
US6451759B1 (en) 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
US6097353A (en) 1998-01-20 2000-08-01 University Of Washington Augmented retinal display with view tracking and data positioning

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030706A1 (en) * 1997-01-07 1998-07-16 The University Of Tennessee Research Corporation Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
WO1999016710A1 (en) * 1997-09-30 1999-04-08 Cel-Sci Corporation Immunogenic conjugated polypeptide for treatment of herpes simplex virus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROSENTHAL K S ET AL: "IMMUNIZATION WITH A LEAPS(TM) HETEROCONJUGATE CONTAINING A CTL EPITOPE AND A PEPTIDE FROM BETA-2-MICROGLOBULIN ELICITS A PROTECTIVE AND DTH RESPONSE TO HERPES SIMPLEX VIRUS TYPE 1", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 17, no. 6, 12 February 1999 (1999-02-12), pages 535 - 542, XP002941023, ISSN: 0264-410X *

Also Published As

Publication number Publication date
WO2001036448A8 (en) 2002-06-20
WO2001036448A3 (en) 2002-02-07
WO2001036448A2 (en) 2001-05-25
EP1223958A2 (en) 2002-07-24
AU4134901A (en) 2001-05-30
JP2003514828A (en) 2003-04-22
EP1964854A2 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
EP0918787A4 (en) Compositions and methods for antisense inhibition of protein translation
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
EP1027309A4 (en) Methods and compositions for enhancing growth of living organisms
NZ328927A (en) Isolating protein from animal muscle tissue free of membrane lipids using low ph composition
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
PL351948A1 (en) Implantable gel compositions and method of making thereof
AU3898300A (en) Methods of and compositions for treating vascular defects
PL339463A1 (en) April - novel protein of growth promoting action
EP1223958A4 (en) Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
HK1080382A1 (en) Compositions and methods for treatment of hyperplasia
AU1219100A (en) Method and kit for rapid preparation of autologous tissue medical devices
AU3347000A (en) Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
IS2595B (en) Protein blend and process for isolating protein mixture from muscle tissue
EP1165586A4 (en) TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
AU3877700A (en) High protein edible compositions and method of preparing the same
ZA976181B (en) Methods of enhancing lean tissue mass and bone mineral content and compositions therefor.
AU7361900A (en) Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
AU1221201A (en) Antisense modulation of y-box binding protein 1 expression
AU2001292917A1 (en) Method of preparing and processing transplant tissue
AU7501801A (en) Composition and method for enhancing elasticity of tissue
AU5003200A (en) Isolation and characterization of epidermal growth factor related protein
AU1590201A (en) Compositions and methods for treating autoimmune diseases and transplant rejections
AU7061200A (en) Compositions and method for treatment of acetaminophen intoxication
AU3471400A (en) Compositions and methods for controlled delivery of virus vectors
EP1177725A4 (en) Method for improving gelling properties of protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020426

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040608

17Q First examination report despatched

Effective date: 20050307

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050920